All Articles

As AI moves from training to production, a new infrastructure battle begins. DeepInfra's Canadian expansion reveals the race for low-latency, global inference.

A new AI agent claims to stop credential theft in seconds. We explore the tech, the human element, and what this means for the future of our digital lives.

With a new name and $35M in fresh funding, Allotera Therapeutics is doubling down on a pivotal trial for Sofi-cel, a therapy aimed at solving a tough T-cell cancer.

At 70, Bay Cities isn't just surviving; it's thriving. A deep dive into how its 100% employee-owned model fuels record growth and future-proofs its strategy.

After a long legal battle, a fabled Cuban beer returns to its founding family, reclaiming its identity and offering a taste of history to a new generation.

A new breed of AI agent from Rulebase promises to do what humans can’t: relentlessly chase stalled financial accounts until the revenue is secured.

FanDuel's expansion into Alberta signals a major shift in Canada's iGaming landscape, promising economic boons, intense competition, and a new era for fans.

Chevron's new licensing deal with ZL Chemicals is more than a press release. It's a strategic masterstroke in monetizing dormant IP and reshaping the EOR market.

A new platform is betting that behavioral data, not headhunters, is the key to success in law and finance. Can an algorithm really fix hiring?

Philips' new Alturion ultrasound system promises efficiency with AI. But can it solve the deeper issues of staff burnout and diagnostic inconsistency?

As AI fights financial crime, one firm's new certification raises a critical question: Can a global standard finally ensure our digital guardians are accountable?

A new service moves beyond data, using AI and human guides to steer patients to affordable care. Is this the strategy that finally bends the healthcare cost curve?

A new deal between genomics giant Illumina and startup Bifrost Biosystems isn't just a business transaction. It’s a strategic play to rewire the very process of drug discovery.

A new, free online hub helps Ontario families navigate the chaos of catastrophic injury, offering clear guidance on care, rehab, and complex insurance systems.

As CCOs face unprecedented challenges from AI and shifting rules, Comply's upcoming ComplyConnect 2026 conference offers a critical forum for real-world strategy.

A 50% surge in small business filings signals deep economic distress, as rising interest rates and consumer debt drive a double-digit increase in bankruptcies nationwide.

A new partnership between Robust.AI and ShipLab reveals a phased, pay-for-performance model that could finally unlock warehouse automation for the masses.

Fabletics' new golf line isn't just about style; it's a calculated move using a powerful data-driven membership model to disrupt a traditional industry.

CorePlus's landmark integration of an AI-powered test marks a pivotal moment for personalized medicine and health equity in the Caribbean.

As Sify Technologies preps its Q1 report, its performance is more than just numbers—it's a critical look into the structural integrity of India's digital future.